P. Pinson

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group

Jan P. van Meerbeeck, C. Debruyne, Nico van Zandwijk et al. · British Journal of Cancer · 1996 · 85 citations · Full text

Malignant Pleural Mesothelioma, Medicine, Pathology +6

Serum Neuron-Specific Enolase as a Tumor Marker in the Diagnosis and Follow-Up of Small-Cell Lung Cancer

P. Pinson, Guy Joos, P. Watripont et al. · Respiration · 1997 · 26 citations

Tumor Innervation, Pathology, Serum Samples +16

Paclitaxel (PTX) as second line treatment in patients (pts) with small cell lung cancer (SCLC) refractory to carboplatin - etoposide: A multicenter phase II study

Guy Joos, Denis Schallier, P. Pinson et al. · Journal of Clinical Oncology · 2004 · 14 citations

Pharmacotherapy, Refractory Pts, Pre-clinical Pharmacology +16

The value of lung function measurements for the assessment of chemotherapy in lung cancer patients

P. Pinson, Jean Klášterský · Lung Cancer · 1998 · 11 citations

Oncology, Advanced Lung Disease, Multiple Pulmonary Nodule +8

Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort study

P. Pinson, Ismael Boussaïd, Justine Decroocq et al. · The Lancet Haematology · 2024 · 10 citations · Full text